Intensity Modulated Radiation Therapy
Customize your policy alerts
Sign up for Ambetter Georgia Policy WA.CP.MP.69 alerts
Get alerted when Policy WA.CP.MP.69 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria and coding guidance for use of intensity-modulated radiotherapy (IMRT) for cancer treatment; intended for providers and claim reviewers administering Ambetter Georgia benefits.
No material clinical or coverage changes in this revision.
Coverage Criteria for IMRT
Medical necessity criteria for IMRT
Covered when ALL of the following are met
Providers should specify the critical structure(s) in the treatment documentation and the rationale for using IMRT to spare that structure.
Clinical documentation should describe the specific concern regarding potential injury to adjacent critical structures if conventional or 3D conformal therapy were used.
The policy history documents code and section changes across prior revisions. Notably, earlier reviews added and removed procedure codes over time (for example, 77370 was added in prior updates and later removed in subsequent annual reviews). The revision log also records structural edits to criteria and alignment with the Health Care Authority billing guidance, and recent updates note the removal of specific CPT and G‑codes (for example, removal of 77385, 77386, and G6015 in the most recent annual review).
IMRT is considered medically necessary only when all policy criteria are met. It is not supported as medically necessary if the criteria are not satisfied — specifically when the treated tumor is not within the specified anatomic areas (head/neck/breast/chest/abdomen/pelvic), when clinical documentation does not identify which critical structure is being spared, or when there is no documented concern that external beam or 3‑D conformal radiation would risk damage to surrounding critical structures.
Coding and Billing Codes
| 77301 | Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications. |
| 77332 | Treatment devices, design and construction; simple. |
| 77333 | Treatment devices, design and construction; intermediate. |
| 77334 | Treatment devices, design and construction; complex. |
| 77338 | Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan. |
| 77370 | Special medical radiation physics consultation. |
Provider Actions, Prior Authorization, and Documentation
Prior authorization and coding
Authorize IMRT only when the medical necessity criteria are met; include the relevant CPT codes (77301, 77332, 77333, 77334, 77338, 77370) on the prior authorization request and ensure clinical documentation specifies the tumor site and which critical structure is being spared.
Provider documentation required for IMRT authorization
Document and submit clinical evidence that meets the policy medical necessity criteria: tumor location within the head/neck/breast/chest/abdomen/pelvic area, identification in notes of the specific critical structure being spared, and documentation that conventional external beam or 3D conformal therapy would risk damage to surrounding critical structures.
- Confirm that all three policy criteria (I.A–I.C) are addressed in submitted records.
- Attach treatment planning details and dose–volume considerations when available to support necessity.
Document the spared critical structure
Clinical notes must explicitly state which critical structure is being spared when IMRT is planned or delivered; this identification is required to meet the policy's documentation criterion.
- Specify the name of the critical structure (e.g., spinal cord, brainstem, optic chiasm) in the clinical record.
- Include treatment planning summaries or dose–volume histograms as supporting documentation when available.
Denial risk for inadequate documentation
Requests for IMRT may be denied if submitted documentation does not demonstrate which critical structure is being spared or if there is no documented concern that conventional or 3‑D conformal therapy would cause damage to surrounding critical structures.
- Absence of a named spared critical structure in clinical notes is grounds for denial.
- Lack of documentation showing concern for damage with conventional/3‑D therapy may result in noncoverage.
Background
Intensity‑modulated radiation therapy (IMRT) is an advanced form of 3‑dimensional conformal radiation therapy that delivers a more precise radiation dose to the tumor while sparing surrounding healthy tissue. The technique modulates beam intensity to better conform dose distributions to irregular tumor shapes and to reduce exposure to adjacent critical structures, which is the basis for the policy requirement that documentation identify which critical structure is being spared and that there be concern about potential damage from conventional or 3‑D conformal techniques.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.